Paper8920173
Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.
Ramanathan K and 2 others. Drugs Aging, 1996. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Thrombolytic therapy in the elderly. Pharmacoeconomic considerations. Papers, record 8920173. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8920173
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocardial Infarction | Major topic |
| Plasminogen Activators | Major topic |
| Thrombolytic Therapy | Major topic |
| Tissue Plasminogen Activator | Major topic |
| Aged | |
| Cost-Benefit Analysis | |
| Humans |
Source PubMed
References46
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 2373810 | Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. | J Am Coll Cardiol | 1990 | https://conductscience.org/library/papers/2373810 | PubMed |
| 2 | 7666904 | Is the use of t-PA as compared with streptokinase cost effective? | N Engl J Med | 1995 | https://conductscience.org/library/papers/7666904 | PubMed |
| 3 | 7585772 | Selecting a thrombolytic agent. | Cardiol Clin | 1995 | https://conductscience.org/library/papers/7585772 | PubMed |
| 4 | 8232430 | The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8232430 | PubMed |
| 5 | 1975321 | GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. | Lancet | 1990 | https://conductscience.org/library/papers/1975321 | PubMed |
| 6 | 7723799 | Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. | N Engl J Med | 1995 | https://conductscience.org/library/papers/7723799 | PubMed |
| 7 | 7666905 | Is the use of t-PA as compared with streptokinase cost effective? | N Engl J Med | 1995 | https://conductscience.org/library/papers/7666905 | PubMed |
| 8 | 3598017 | Cardiovascular care of the elderly: economic considerations. | J Am Coll Cardiol | 1987 | https://conductscience.org/library/papers/3598017 | PubMed |
| 9 | 2894490 | Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group. | Lancet | 1988 | https://conductscience.org/library/papers/2894490 | PubMed |
| 10 | 2871492 | A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days. | N Engl J Med | 1986 | https://conductscience.org/library/papers/2871492 | PubMed |
| 11 | 8475884 | Thrombolytic therapy for acute myocardial infarction in a 110-year-old man. | Am J Cardiol | 1993 | https://conductscience.org/library/papers/8475884 | PubMed |
| 12 | 1975322 | In-hospital mortality and clinical course of 20,891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin. The International Study Group. | Lancet | 1990 | https://conductscience.org/library/papers/1975322 | PubMed |
| 13 | 1452917 | Long-term survival in 618 patients from the Western Washington Streptokinase in Myocardial Infarction trials. | J Am Coll Cardiol | 1992 | https://conductscience.org/library/papers/1452917 | PubMed |
| 14 | 3132962 | Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The Netherlands. | Br Heart J | 1988 | https://conductscience.org/library/papers/3132962 | PubMed |
| 15 | 2900919 | Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). | Lancet | 1988 | https://conductscience.org/library/papers/2900919 | PubMed |
| 16 | 4178977 | A new coronary prognostic index. | Lancet | 1969 | https://conductscience.org/library/papers/4178977 | PubMed |
| 17 | 2868337 | Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). | Lancet | 1986 | https://conductscience.org/library/papers/2868337 | PubMed |
| 18 | 2002574 | Coronary thrombolysis for the elderly? | JAMA | 1991 | https://conductscience.org/library/papers/2002574 | PubMed |
| 19 | 1869726 | Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. | J Am Coll Cardiol | 1991 | https://conductscience.org/library/papers/1869726 | PubMed |
| 20 | 8070474 | Eligibility for reperfusion therapy and outcome in elderly patients with acute myocardial infarction. | Eur Heart J | 1994 | https://conductscience.org/library/papers/8070474 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11558833 | Management of acute ischaemic stroke in the elderly: tolerability of thrombolytics. | Drugs | 2001 | https://conductscience.org/library/papers/11558833 | PubMed |
| 10408741 | Thrombolysis versus primary angioplasty in older patients with acute myocardial infarction. | Drugs Aging | 1999 | https://conductscience.org/library/papers/10408741 | PubMed |
| 9883399 | Utilisation of thrombolytic therapy in older patients with myocardial infarction. | Drugs Aging | 1998 | https://conductscience.org/library/papers/9883399 | PubMed |
| 9812927 | Age related outcome in acute myocardial infarction. Elderly people benefit from thrombolysis and should be included in trials. | BMJ | 1998 | https://conductscience.org/library/papers/9812927 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8920173
GET https://conductscience.org/api/papers/v1/8920173/references?page=2